CURE Pharmaceutical Holding Corp has entered into a partnership with Canadian cannabis giant Canopy Growth Corp to develop a CBD product together.
The companies will be working on a low-dose CBD oral thin film that will use CURE Pharmaceutical’s patented CUREfilm technology. Canopy Growth will license the technology for global distribution.
CUREfilm will offer Canopy Growth a dosage that is “ideal for administering cannabinoids,” CURE said in a statement.
Read full coverage:
Canopy Growth, CURE Pharmaceutical To Work Together On CBD Oral Thin Films (Benzinga)
CURE Pharmaceutical, Canopy Growth to make CBD oral thin films (Seeking Alpha)
